Receptor-targeting phthalocyanine photosensitizer for improving antitumor photocytotoxicity

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Xu, Peng ^a,b   Chen, Jincan ^a,b   Chen, Zhuo ^a,b   Zhou, Shanyong ^a   Hu, Ping ^a   Chen, Xueyuan ^b,c   Huang, Mingdong ^a,b  

^a FUJIAN INSTITUTE OF RESEARCH ON THE STRUCTURE OF MATTER   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^c FUJIAN INSTITUTE OF RESEARCH ON THE STRUCTURE OF MATTER   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CETRORELIX; GONADORELIN RECEPTOR; GONADOTROPIN RELEASING HORMONE ZINC PHTHALOCYANINE CONJUGATE; SINGLET OXYGEN; UNCLASSIFIED DRUG; GONADORELIN; INDOLE DERIVATIVE; ORGANOMETALLIC COMPOUND; PHOTOSENSITIZING AGENT; ZN(II) PHTHALOCYANINE; ZN(II)-PHTHALOCYANINE;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CONTROLLED STUDY; CYTOTOXICITY; DRUG SYNTHESIS; DRUG TARGETING; DRUG UPTAKE; FLUORESCENCE; HUMAN; HUMAN CELL; IC 50; PHOTODYNAMICS; PHOTOTOXICITY; QUANTUM YIELD; CELL PROLIFERATION; CHEMISTRY; DARKNESS; DRUG ANTAGONISM; DRUG EFFECT; METABOLISM; MOLECULARLY TARGETED THERAPY; NEOPLASM; PATHOLOGY; PHOTOCHEMOTHERAPY; PHYSICAL CHEMISTRY; RADIATION EXPOSURE; SYNTHESIS; TRANSPORT AT THE CELLULAR LEVEL; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; BIOLOGICAL TRANSPORT; CELL LINE, TUMOR; CELL PROLIFERATION; DARKNESS; GONADOTROPIN-RELEASING HORMONE; HUMANS; INDOLES; MOLECULAR TARGETED THERAPY; NEOPLASMS; ORGANOMETALLIC COMPOUNDS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PHYSICOCHEMICAL PROCESSES; RECEPTORS, LHRH;

EID: 84861690057     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0037051     Document Type: Article

References (45)

1. World Health Organization (2011) Fact sheet Nr. 297. World Health Organization (WHO).
2. Sharman WM, Allen CM, van Lier JE, (1999) Photodynamic therapeutics: basic principles and clinical applications. Drug Discovery Today 4: 507-517.
3. Dougherty TJ, (1993) Photodynamic therapy. Photochem Photobiol 58: 895-900.
4. Vrouenraets MB, Visser GW, Snow GB, van Dongen GA, (2003) Basic principles, applications in oncology and improved selectivity of photodynamic therapy. Anticancer Res 23: 505-522.
5. Allen CM, Sharman WM, van Lier JE, (2002) Photodynamic therapy: targeting cancer cells with photosensitizer-bioconjugates. Tumour Targeting in Cancer Therapy Humana Press, New Jersey pp. 329-361.
6. Sharman WM, van Lier JE, Allen CM, (2004) Targeted photodynamic therapy via receptor mediated delivery systems. Adv Drug Deliv Rev 56: 53-76.
7. Taquet JP, Frochot C, Manneville V, Barberi-Heyob M, (2007) Phthalocyanines covalently bound to biomolecules for a targeted photodynamic therapy. Current Medicinal Chemistry 14: 1673-1687.
8. Chen Z, Zhou SY, Chen JC, Deng YC, Luo ZP, et al. (2010) Pentalysine beta-Carbonylphthalocyanine Zinc: An Effective Tumor-Targeting Photosensitizer for Photodynamic Therapy. Chemmedchem 5: 890-898.
9. Kakar SS, Malik MT, Winters SJ, Mazhawidza W, (2004) Gonadotropin-releasing hormone receptors: structure, expression, and signaling transduction. Vitam Horm 69: 151-207.
10. Nagy A, Schally AV, (2005) Targeting of cytotoxic luteinizing hormone-releasing hormone analogs to breast, ovarian, endometrial, and prostate cancers. Biol Reprod 73: 851-859.
11. Keller G, Schally AV, Gaiser T, Nagy A, Baker B, et al. (2005) Human malignant melanomas express receptors for luteinizing hormone releasing hormone allowing targeted therapy with cytotoxic luteinizing hormone releasing hormone analogue. Cancer Res 65: 5857-5863.
12. Kakar SS, Jin H, Hong B, Eaton JW, Kang KA, (2008) LHRH receptor targeted therapy for breast cancer. Oxygen Transport to Tissue Xxix 614: 285-296.
13. Nagy A, Schally AV, Armatis P, Szepeshazi K, Halmos G, et al. (1996) Cytotoxic analogs of luteinizing hormone-releasing hormone containing doxorubicin or 2-pyrrolinodoxorubicin, a derivative 500-1000 times more potent. Proceedings of the National Academy of Sciences of the United States of America 93: 7269-7273.
14. Janaky T, Juhasz A, Bajusz S, Csernus V, Srkalovic G, et al. (1992) Analogues of luteinizing hormone-releasing hormone containing cytotoxic groups. Proc Natl Acad Sci U S A 89: 972-976.
15. Bajusz S, Janaky T, Csernus VJ, Bokser L, Fekete M, et al. (1989) Highly potent analogues of luteinizing hormone-releasing hormone containing D-phenylalanine nitrogen mustard in position 6. Proc Natl Acad Sci U S A 86: 6318-6322.
16. Leuschner C, Kumar C, Hansel W, Soboyejo W, Zhou JK, et al. (2006) LHRH-conjugated magnetic iron oxide nanoparticles for detection of breast cancer metastases. Breast Cancer Research and Treatment 99: 163-176.
17. Xu C, Yuan Z, Kohler N, Kim J, Chung MA, et al. (2009) FePt Nanoparticles as an Fe Reservoir for Controlled Fe Release and Tumor Inhibition. Journal of the American Chemical Society 131: 15346-15351.
18. Kovacs M, Schally AV, Nagy A, Koppan M, Groot K, (1997) Recovery of pituitary function after treatment with a targeted cytotoxic analog of luteinizing hormone-releasing hormone. Proc Natl Acad Sci U S A 94: 1420-1425.
19. Chen J, Chen N, Huang J, Wang J, Huang M, (2006) Derivatizable phthalocyanine with single carboxyl group: Synthesis and purification. Inorganic Chemistry Communications 9: 313-315.
20. Ogunsipe A, Chen J-Y, Nyokong T, (2004) Photophysical and photochemical studies of zinc(ii) phthalocyanine derivatives?effects of substituents and solvents. New Journal of Chemistry 28: 822-827.
21. Kuznetsova NA, Gretsova NS, Kalmykova EA, Makarova EA, Dashkevich SN, et al. (2000) Relationship between the photochemical properties and structure of pophyrins and related compounds. Russian Journal of General Chemistry 70: 133-140.
22. Chen J, Chen Z, Zheng Y, Zhou S, Wang J, et al. (2011) Substituted zinc phthalocyanine as an antimicrobial photosensitizer for periodontitis treatment. Journal of Porphyrins and Phthalocyanines 15: 293.
23. Bi{dotless}yi{dotless}kli{dotless}oǧlu Z, Durmuş M, Kantekin H, (2010) Synthesis, photophysical and photochemical properties of quinoline substituted zinc (II) phthalocyanines and their quaternized derivatives. Journal of Photochemistry and Photobiology A: Chemistry 211: 32-41.
24. Nyk M, Palewska K, Kepinski L, Wilk KA, Strek W, et al. (2010) Fluorescence resonance energy transfer in a non-conjugated system of CdSe quantum dots/zinc-phthalocyanine. Journal of Luminescence 130: 2487-2490.
25. Leuschner C, Enright FM, Gawronska B, Hansel W, (2003) Membrane disrupting lytic peptide conjugates destroy hormone dependent and independent breast cancer cells in vitro and in vivo. Breast Cancer Research and Treatment 78: 17-27.
26. Kakar SS, Grizzle WE, Neill JD, (1994) The nucleotide sequences of human GnRH receptors in breast and ovarian tumors are identical with that found in pituitary. Mol Cell Endocrinol 106: 145-149.
27. Eidne KA, Flanagan CA, Harris NS, Millar RP, (1987) Gonadotropin-releasing hormone (GnRH)-binding sites in human breast cancer cell lines and inhibitory effects of GnRH antagonists. J Clin Endocrinol Metab 64: 425-432.
28. Morgan K, Stewart AJ, Miller N, Mullen P, Muir M, et al. (2008) Gonadotropin-releasing hormone receptor levels and cell context affect tumor cell responses to agonist in vitro and in vivo. Cancer Research 68: 6331-6340.
29. Harrison GS, Wierman ME, Nett TM, Glode LM, (2004) Gonadotropin-releasing hormone and its receptor in normal and malignant cells. Endocr Relat Cancer 11: 725-748.
30. Rahimipour S, Ben-Aroya N, Ziv K, Chen A, Fridkin M, et al. (2003) Receptor-mediated targeting of a photosensitizer by its conjugation to gonadotropin-releasing hormone analogues. Journal of Medicinal Chemistry 46: 3965-3974.
31. Allen CM, Sharman WM, Van Lier JE, (2001) Current status of phthalocyanines in the photodynamic therapy of cancer. Journal of Porphyrins and Phthalocyanines 5: 161-169.
32. Ethirajan M, Chen Y, Joshi P, Pandey RK, (2011) The role of porphyrin chemistry in tumor imaging and photodynamic therapy. Chem Soc Rev 40: 340-362.
33. Smirnova ZS, Oborotova NA, Makarova OA, Orlova OL, Polozkova AP, et al. (2005) Efficiency and pharmacokinetics of photosense: A new liposomal photosensitizer formulation based on aluminum sulfophthalocyanine. Khimiko-Farmatsevticheskii Zhurnal 39: 3-7.
34. Avetisov SE, Budzinskaia MV, Kiseleva TN, Kazarian EE, Gurova IV, et al. (2007) Photodynamic therapy for subretinal neovascular membranes. Communication 1. Results of treatment for age-related macular degeneration. Vestn Oftalmol 123: 3-7.
35. Chen J, Chen H, Li Y, Wang J, Chen N, et al. (2008) Synthesis and Photodynamic Activity of a New Type of Pentalysine 2-Carbonylphthalocyanine Zinc. Chemical Research In Chinese Universities 29: 2131-2137.
36. Sharman WM, van Lier JE, (2005) Synthesis and photodynamic activity of novel asymmetrically substituted fluorinated phthalocyanines. Bioconjug Chem 16: 1166-1175.
37. Liu JY, Lo PC, Fong WP, Ng DK, (2009) Effects of the number and position of the substituents on the in vitro photodynamic activities of glucosylated zinc(II) phthalocyanines. Org Biomol Chem 7: 1583-1591.
38. Bai M, Lo PC, Ye J, Wu C, Fong WP, et al. (2011) Facile synthesis of pegylated zinc(II) phthalocyanines via transesterification and their in vitro photodynamic activities. Org Biomol Chem 9: 7028-7032.
39. Lo PC, Zhao B, Duan W, Fong WP, Ko WH, et al. (2007) Synthesis and in vitro photodynamic activity of mono-substituted amphiphilic zinc(II) phthalocyanines. Bioorganic & Medicinal Chemistry Letters 17: 1073-1077.
40. Brasseur N, Langlois R, La Madeleine C, Ouellet R, van Lier JE, (1999) Receptor-mediated targeting of phthalocyanines to macrophages via covalent coupling to native or maleylated bovine serum albumin. Photochem Photobiol 69: 345-352.
41. Carcenac M, Larroque C, Langlois R, van Lier JE, Artus JC, et al. (1999) Preparation, phototoxicity and biodistribution studies of anti-carcinoembryonic antigen monoclonal antibody-phthalocyanine conjugates. Photochem Photobiol 70: 930-936.
42. Stefflova K, Chen J, Marotta D, Li H, Zheng G, (2006) Photodynamic therapy agent with a built-in apoptosis sensor for evaluating its own therapeutic outcome in situ. J Med Chem 49: 3850-3856.
43. Choi Y, McCarthy JR, Weissleder R, Tung CH, (2006) Conjugation of a photosensitizer to an oligoarginine-based cell-penetrating peptide increases the efficacy of photodynamic therapy. ChemMedChem 1: 458-463.
44. Tirand L, Frochot C, Vanderesse R, Thomas N, Trinquet E, et al. (2006) A peptide competing with VEGF165 binding on neuropilin-1 mediates targeting of a chlorin-type photosensitizer and potentiates its photodynamic activity in human endothelial cells. J Control Release 111: 153-164.
45. Huang J, Liu E, Yang S, Chen N, Duan J, et al. (2000) [The monomer electronic spectra and fluorescence spectra of some metal phthalocyanines]. Guang Pu Xue Yu Guang Pu Fen Xi 20: 95-98.